CREB1-induced lncRNA LEF1-AS1 contributes to colorectal cancer progression via the miR-489/DIAPH1 axis

被引:19
作者
Cheng, Yan [1 ]
Wu, Jing [1 ]
Qin, Bin [1 ]
Zou, Bai-cang [1 ]
Wang, Yong-hua [1 ]
Li, Yang [2 ]
机构
[1] Xi An Jiao Tong Univ, Dept Digest Dis, Affiliated Hosp 2, Xian, Shaanxi, Peoples R China
[2] Xi An Jiao Tong Univ, Dept Otolaryngol Head & Neck Surg, Affiliated Hosp 2, 157 Xiwu Rd, Xian 710004, Shaanxi, Peoples R China
关键词
LncRNA LEF1-AS1; miR-489; DIAPH1; Biomarker; Colorectal cancer; Metastasis; LONG NONCODING RNAS; STATISTICS;
D O I
10.1016/j.bbrc.2020.03.153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Long non-coding RNAs (lncRNAs) have been identified as new regulatory factors in tumor progression. Lymphoid enhancer-binding factor 1 antisense RNA 1 (LEF1-AS1) was a recently identified lncRNA. This research aimed to investigate the roles and mechanisms of LEF1-AS1 in colorectal cancer (CRC). We firstly showed that LEF1-AS1 expression was upregulated in human CRC tissues and cell lines. LEF1-AS1 upregulation was demonstrated to be induced by CREB1. Clinical study revealed that high LEF1-AS1 expression was positively associated with histological grade, lymph nodes metastasis, and decreased survivals of CRC patients. Functionally, down-regulation of LEF1-AS1 using si-LEF1-AS1 decreased cell growth, migration and invasion, as well as increased apoptosis in CRC cells. Mechanically, LEF1-AS1 functioned as competing endogenous RNA (ceRNA) for miR-489 to positively recover DIAPH1, thus playing an oncogenic role in CRC pathogenesis. Overall, our observations identified a novel CRC-related lncRNA LEF1-AS1 and discovered a critical role for this lncRNA as a ceRNA in CRC pathogenesis, suggesting that it may serve as a novel biomarker for prognosis and act as a therapeutic target for CRC treatment. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:678 / 684
页数:7
相关论文
共 26 条
[1]   Novel loss-of-function variants in DIAPH1 associated with syndromic microcephaly, blindness, and early onset seizures [J].
Al-Maawali, Almundher ;
Barry, Brenda J. ;
Rajab, Anna ;
El-Quessny, Malak ;
Seman, Ann ;
Coury, Stephanie Newton ;
Barkovich, A. James ;
Yang, Edward ;
Walsh, Christopher A. ;
Mochida, Ganeshwaran H. ;
Stoler, Joan M. .
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2016, 170 (02) :435-440
[2]   Long Noncoding RNAs as Biomarkers in Cancer [J].
Bolha, Luka ;
Ravnik-Glavac, Metka ;
Glavac, Damjan .
DISEASE MARKERS, 2017, 2017
[3]   Cancer Statistics in China, 2015 [J].
Chen, Wanqing ;
Zheng, Rongshou ;
Baade, Peter D. ;
Zhang, Siwei ;
Zeng, Hongmei ;
Bray, Freddie ;
Jemal, Ahmedin ;
Yu, Xue Qin ;
He, Jie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132
[4]   Identification of dysregulated lncRNAs profiling and metastasis-associated lncRNAs in colorectal cancer by genome-wide analysis [J].
Chen, Yan ;
Yu, Xiang ;
Xu, Yongcan ;
Shen, Hua .
CANCER MEDICINE, 2017, 6 (10) :2321-2330
[5]   Transcriptional and Post-transcriptional Gene Regulation by Long Non-coding RNA [J].
Dykes, Iain M. ;
Emanueli, Costanza .
GENOMICS PROTEOMICS & BIOINFORMATICS, 2017, 15 (03) :177-186
[6]   MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer [J].
Gao, S. ;
Liu, H. ;
Hou, S. ;
Wu, L. ;
Yang, Z. ;
Shen, J. ;
Zhou, L. ;
Zheng, S. -S. ;
Jiang, B. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06) :703-712
[7]   Colorectal Cancer Screening [J].
Garborg, Kjetil .
SURGICAL CLINICS OF NORTH AMERICA, 2015, 95 (05) :979-+
[8]   History, Discovery, and Classification of lncRNAs [J].
Jarroux, Julien ;
Morillon, Antonin ;
Pinskaya, Marina .
LONG NON CODING RNA BIOLOGY, 2017, 1008 :1-46
[9]   MiR-489 regulates chemoresistance in breast cancer via epithelial mesenchymal transition pathway [J].
Jiang, Li ;
He, Dongxu ;
Yang, Dantong ;
Chen, Zhen ;
Pan, Qiongxi ;
Mao, Aiqin ;
Cai, Yanfei ;
Li, Xiyuan ;
Xing, Hui ;
Shi, Mei ;
Chen, Yun ;
Bruce, Iain C. ;
Wang, Teng ;
Jin, Linfang ;
Qi, Xiaowei ;
Hua, Dong ;
Jin, Jian ;
Ma, Xin .
FEBS LETTERS, 2014, 588 (11) :2009-2015
[10]   Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances [J].
Lech, Gustaw ;
Slotwinski, Robert ;
Slodkowski, Maciej ;
Krasnodebski, Ireneusz Wojciech .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (05) :1745-1755